Bio-Rad Lab

Forecast & Rating5 analysts currently cover Bio-Rad Lab, with about 20.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $329.00, about 12.6% downside from the current price of $376.41. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 28.4% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Bio-Rad Lab's outlook. Data as of Sep 10, 2026; for reference only and not investment advice.